KALA BIO, Inc.
KALA
$0.58
$0.024.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -0.23% | 18.65% | 28.84% | -4.22% | -7.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.81% | -14.62% | 4.88% | 3.29% | -1.71% |
| Operating Income | 39.81% | 14.62% | -4.88% | -3.29% | 1.71% |
| Income Before Tax | 72.92% | 44.87% | 29.94% | 8.01% | 3.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 72.92% | 44.87% | 29.94% | 8.01% | 3.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 72.92% | 44.87% | 29.94% | 8.01% | 3.85% |
| EBIT | 39.81% | 14.62% | -4.88% | -3.29% | 1.71% |
| EBITDA | 40.25% | 14.89% | -4.77% | -3.13% | 1.70% |
| EPS Basic | 78.68% | 66.83% | 62.45% | 52.39% | 51.27% |
| Normalized Basic EPS | 60.83% | 52.47% | 51.51% | 41.74% | 49.52% |
| EPS Diluted | 78.68% | 66.83% | 62.45% | 52.39% | 51.27% |
| Normalized Diluted EPS | 60.83% | 52.47% | 51.51% | 41.74% | 49.52% |
| Average Basic Shares Outstanding | 2,681.68% | 3,215.08% | 114.80% | 86.47% | 99.68% |
| Average Diluted Shares Outstanding | 2,681.68% | 3,215.08% | 114.80% | 86.47% | 99.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |